Three overarching ADNI goals are:
- To detect Alzheimerâs disease (AD) at the earliest stage possible and identify ways to track the disease through biomarkers.
- To support advances in AD intervention, prevention and treatment through the application of new diagnostic methods to apply at the earliest stages technically possible - when intervention may be most effective.
- To continually develop ADNIâs now- legendary data access policy and continuously improve and expand the unprecedented data sharing model.
ADNI began in October 2004 and was designed to find more sensitive and accurate methods to detect Alzheimerâs disease at earlier stages and mark its progress through biomarkers. The study gathered and analyzed thousands of brain scans, genetic profiles, and biomarkers in blood and cerebrospinal fluid that are used to measure the progress of disease or the effects of treatment.
Definition contributed by Anonymous
clock drawing task
American National Adult Reading Test
boston naming test
Trail Making Test A and B
category fluency test
backward digit span task
forward digit span task
Rey Auditory Verbal Learning Task
Mini Mental State Examination
No batteries have been added.
No indicators have yet been associated.
An indicator is a specific quantitative or qualitative variable that is recorded for analysis. These may include behavioral variables (such as response time, accuracy, or other measures of performance) or physiological variables (including genetics, psychophysiology, or brain imaging data).
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L
Alzheimer's & dementia : the journal of the Alzheimer's Association (Alzheimers Dement)